nephrology Archives

VU Inside: Dr. William Fissell’s Artificial Kidney

Feb. 12, 2016—Vanderbilt University Medical Center nephrologist and Associate Professor of Medicine Dr. William Fissell IV is making major progress on a first-of-its kind device to free kidney patients from dialysis. He is building an artificial implantable kidney with microchip filters and living kidney cells that will be powered by a patient’s own heart.

Million Veteran Program data spurs research in pharmacogenomics of kidney disease

Aug. 13, 2015—A team of Vanderbilt and Nashville VA researchers, led by Adriana Hung, M.D., MPH, has been awarded a grant from the U.S. Department of Veterans Affairs to use the Million Veteran Program (MVP) data to conduct diabetes research.

Study: Why one kidney can work as well as two

Jun. 11, 2015—Vanderbilt University researchers have come closer to solving a mystery that has puzzled scientists for more than a century: after the loss of one kidney, what causes the growth of the remaining kidney to take up the slack?

Surprising finding in the kidney

Apr. 16, 2015—TGF-beta signaling in the kidney was thought to be a target for reducing renal fibrosis, but Vanderbilt researchers report that fibrosis still occurs in the absence of TGF-beta signaling.

NIH grant spurs diabetic nephropathy research

Oct. 30, 2014—Diabetic nephropathy, or kidney disease caused by diabetes, is a major source of morbidity and mortality. In the United States, more than 30 percent of patients receiving either dialytic therapy or renal transplantation have end stage renal disease as a result of diabetic nephropathy.

Stallworth debuts hemodialysis service for rehab patients

Sep. 4, 2014—Vanderbilt Stallworth Rehabilitation Hospital (VSRH) is now offering hemodialysis for its patients, eliminating the need to transport them off site for treatment.

Study tracks new end-stage renal disease therapy

Aug. 7, 2014—Researchers in Vanderbilt’s Division of Nephrology conducted a Phase 3 clinical trial to test the safety and efficacy of a new drug to treat patients with end-stage renal disease.

Nighttime dialysis treatments available

May. 8, 2014—Vanderbilt University Medical Center, committed to providing multiple options to patients who have kidney disease, recently began offering nocturnal in-center hemodialysis, which allows patients to receive treatment at night while they sleep.

Research effort seeks to improve home care for kidney failure patients

Jun. 27, 2013—Vanderbilt nephrologist, Thomas Golper, M.D., professor of Medicine in Nephrology and Hypertension, is leading an effort to form a research consortium with a goal of improving care for kidney failure patients who receive a form of home dialysis.